{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:22Z","timestamp":1793194822519,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.lungcan.2022.03.014","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T11:47:55Z","timestamp":1647690475000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Prognostic impact of inflammation in malignant pleural mesothelioma: A large-scale analysis of consecutive patients"],"prefix":"10.1016","volume":"166","author":[{"given":"Ludovic","family":"Fournel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Charrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Huriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Iaffaldano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Arrondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lungcan.2022.03.014_b0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.thorsurg.2004.06.011","article-title":"Epidemiology, biologic behavior, and natural history of mesothelioma","volume":"14","author":"Zellos","year":"2004","journal-title":"Thorac. Surg. Clin."},{"issue":"7","key":"10.1016\/j.lungcan.2022.03.014_b0010","first-page":"1031","article-title":"Epidemiology of environmental exposure and malignant mesothelioma","volume":"12","author":"Liu","year":"2017","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2022.03.014_b0015","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/oemed-2017-104383","article-title":"Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis","volume":"74","author":"Marsh","year":"2017","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.lungcan.2022.03.014_b0020","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","author":"Popat","year":"2021","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.014_b0025","doi-asserted-by":"crossref","first-page":"e001601","DOI":"10.1136\/jitc-2020-001601","article-title":"Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification","volume":"9","author":"Alay","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2022.03.014_b0030","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1016\/S2589-7500(21)00104-7","article-title":"The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study","volume":"3","author":"Zauderer","year":"2021","journal-title":"Lancet Digit. Health"},{"issue":"1","key":"10.1016\/j.lungcan.2022.03.014_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2022.03.014_b0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2022.03.014_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lungcan.2021.11.001","article-title":"Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013\u20132017: A nationwide CAS registry analysis from the I-O Optimise initiative","volume":"162","author":"Baas","year":"2021","journal-title":"Lung Cancer Amst. Neth."},{"key":"10.1016\/j.lungcan.2022.03.014_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01361","article-title":"Development and validation of a prognostic signature for malignant pleural mesothelioma","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2022.03.014_b0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jtcvs.2012.09.023","article-title":"Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and\/or pleurodesis","volume":"145","author":"Baud","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"34","key":"10.1016\/j.lungcan.2022.03.014_b0060","doi-asserted-by":"crossref","first-page":"57460","DOI":"10.18632\/oncotarget.15404","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.014_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5301\/tj.5000418","article-title":"Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma","volume":"102","author":"Berardi","year":"2016","journal-title":"Tumori"},{"key":"10.1016\/j.lungcan.2022.03.014_b0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2022.03.014_b0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lungcan.2022.03.014_b0080","first-page":"587","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"Pinato","year":"2012","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"23","key":"10.1016\/j.lungcan.2022.03.014_b0085","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","article-title":"High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy","volume":"16","author":"Kao","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.lungcan.2022.03.014_b0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.21037\/atm.2019.09.18","article-title":"Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer","volume":"7","author":"Berardi","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2022.03.014_b0095","first-page":"900","article-title":"Plasma biomarker enrichment of clinical prognostic indices in malignant pleural mesothelioma","volume":"11","author":"Pass","year":"2016","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2022.03.014_b0100","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/bjc.2013.504","article-title":"Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma","volume":"109","author":"Meniawy","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2022.03.014_b0105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1245\/s10434-018-6385-x","article-title":"The C-reactive protein\/albumin ratio is a novel significant prognostic factor in patients with malignant pleural mesothelioma: a retrospective multi-institutional study","volume":"25","author":"Takamori","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.lungcan.2022.03.014_b0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra1912719","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Longo","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.014_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14712598.2020.1703945","article-title":"Nivolumab for the treatment of unresectable pleural mesothelioma","volume":"20","author":"Hotta","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"issue":"22","key":"10.1016\/j.lungcan.2022.03.014_b0120","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.3390\/cancers13225664","article-title":"Mesothelioma malignancy and the microenvironment: molecular mechanisms","volume":"13","author":"Cersosimo","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.014_b0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/crj.12574","article-title":"Relation between neutrophil\/lymphocyte ratio and primary tumor metabolic activity in patients with malign pleural mesothelioma","volume":"12","author":"\u00d6zy\u00fcrek","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"11","key":"10.1016\/j.lungcan.2022.03.014_b0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.21037\/atm.2020.03.174","article-title":"Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer","volume":"8","author":"Alifano","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lungcan.2022.03.014_b0135","doi-asserted-by":"crossref","unstructured":"I. P, I. A, L. H, and A. M, \u201cSarcopenia in resected non-small cell lung cancer: let\u2019s move to patient-directed strategies,\u201d J. Thorac. Dis., 10(Suppl 26), 2018, doi: 10.21037\/jtd.2018.08.34.","DOI":"10.21037\/jtd.2018.08.34"},{"issue":"18","key":"10.1016\/j.lungcan.2022.03.014_b0140","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/cancers13184574","article-title":"The Reality of Lung Cancer Paradox: The Impact of Body Mass Index on Long-Term Survival of Resected Lung Cancer. A French Nationwide Analysis from the Epithor Database","volume":"13","author":"Alifano","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.lungcan.2022.03.014_b0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/cancers12020266","article-title":"Pre-disease and pre-surgery BMI, weight loss and sarcopenia impact survival of resected lung cancer independently of tumor stage","volume":"12","author":"Icard","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.lungcan.2022.03.014_b0150","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/COC.0000000000000745","article-title":"Gender differences in outcomes of patients with mesothelioma","volume":"43","author":"Alpert","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.lungcan.2022.03.014_b0155","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.lungcan.2022.03.014_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106914","article-title":"Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer","volume":"9","author":"Alifano","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lungcan.2022.03.014_b0165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00262-011-1073-8","article-title":"Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients","volume":"60","author":"Suzuki","year":"2011","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"3","key":"10.1016\/j.lungcan.2022.03.014_b0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0000000000001416","article-title":"Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting: An External Validation Study of 563 Cases","volume":"44","author":"Zhang","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.03.014_b0175","first-page":"29","article-title":"EURACAN\/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach","volume":"15","author":"Nicholson","year":"2020","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2022.03.014_b0180","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s11033-019-04715-9","article-title":"Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma","volume":"46","author":"Sobhani","year":"2019","journal-title":"Mol. Biol. Rep."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022200383X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022200383X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:02:54Z","timestamp":1759237374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950022200383X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":36,"alternative-id":["S016950022200383X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.03.014","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of inflammation in malignant pleural mesothelioma: A large-scale analysis of consecutive patients","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}